Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4531637
Max Phase: Preclinical
Molecular Formula: C20H31N5O4
Molecular Weight: 405.50
Molecule Type: Unknown
Associated Items:
ID: ALA4531637
Max Phase: Preclinical
Molecular Formula: C20H31N5O4
Molecular Weight: 405.50
Molecule Type: Unknown
Associated Items:
Canonical SMILES: CC(C)[C@@H](CC(=O)Nc1cncc(C(=O)O)c1N)NC(=O)[C@@H](N)C1CCCCC1
Standard InChI: InChI=1S/C20H31N5O4/c1-11(2)14(25-19(27)17(21)12-6-4-3-5-7-12)8-16(26)24-15-10-23-9-13(18(15)22)20(28)29/h9-12,14,17H,3-8,21H2,1-2H3,(H2,22,23)(H,24,26)(H,25,27)(H,28,29)/t14-,17+/m1/s1
Standard InChI Key: AJIIQRPBBIGIJS-PBHICJAKSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 405.50 | Molecular Weight (Monoisotopic): 405.2376 | AlogP: 1.74 | #Rotatable Bonds: 8 |
Polar Surface Area: 160.43 | Molecular Species: ZWITTERION | HBA: 6 | HBD: 5 |
#RO5 Violations: 0 | HBA (Lipinski): 9 | HBD (Lipinski): 7 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: 3.66 | CX Basic pKa: 9.33 | CX LogP: -0.62 | CX LogD: -0.99 |
Aromatic Rings: 1 | Heavy Atoms: 29 | QED Weighted: 0.44 | Np Likeness Score: -0.24 |
1. Yamada K, Nakazawa M, Matsumoto K, Tagami U, Hirokawa T, Homma K, Mori S, Matsumoto R, Saikawa W, Kitajima S.. (2019) Unnatural Tripeptides as Potent Positive Allosteric Modulators of T1R2/T1R3., 10 (5): [PMID:31098002] [10.1021/acsmedchemlett.9b00051] |
Source(1):